Spots Global Cancer Trial Database for cancer of stomach
Every month we try and update this database with for cancer of stomach cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer | NCT03347162 | Cancer Cancer of Pancr... Cancer of Liver Cancer of Esoph... Cancer of Stoma... Cancer, Metasta... | 18 Years - | Rigshospitalet, Denmark | ||
| SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry | NCT03452774 | Cancer, Metasta... Cancer Cancer of Pancr... Cancer of Liver Cancer of Stoma... Cancer Liver Cancer of Rectu... Cancer of Kidne... Cancer of Esoph... Cancer of Cervi... Cancer of Colon Cancer of Laryn... Cancer, Lung Cancer, Breast Cancer, Advance... Cancer Prostate Cancer of Neck Cancer of Skin Neuroendocrine ... Carcinoma Mismatch Repair... BRCA Gene Rearr... Non Hodgkin Lym... Leukemia Non Small Cell ... Cholangiocarcin... Glioblastoma Central Nervous... Melanoma Urothelial Carc... Bladder Cancer Ovarian Cancer Endometrial Can... Testicular Canc... Breast Cancer COVID Myelofibrosis Myeloproliferat... Myeloproliferat... Follicular Lymp... Mantle Cell Lym... Marginal Zone L... Myelodysplastic... | Clinical Trial ... | - | Massive Bio, Inc. | |
| Genomic Testing and Resulting Medical Decisions | NCT03301493 | Cancer of Unkno... Cancer Refracto... Cancer of Stoma... Cancer Head Nec... Cancer of Skin Cancer, Lung Cancer Colorect... Cancer of Esoph... Cancer, Bladder Cancer, Uterus Cancer Cervix Cancer Liver Cancer, Kidney Cancer, Breast Hematologic Neo... | Genomic testing | 18 Years - | Arbeitsgemeinschaft medikamentoese Tumortherapie | |
| Investigation of an Abdominal Compression Device | NCT04270890 | Cancer, Lung Cancer of Stoma... | Abdominal compr... | 18 Years - | The Clatterbridge Cancer Centre NHS Foundation Trust | |
| NAB-PACLITAXEL Plus FOLFOX as Perioperative Chemotherapy in Patients With Operable Oesogastric Adenocarcinoma | NCT02486601 | Cancer of Stoma... | nab-paclitaxel FOLFOX | 18 Years - | GERCOR - Multidisciplinary Oncology Cooperative Group | |
| Early IntraVenous Administration of Nutritional Support | NCT03949907 | Cancer of Stoma... GastroEsophagea... | Nutritional cou... Early supplemen... | 18 Years - | IRCCS Policlinico S. Matteo | |
| Omentectomy vs Omental Preservation in Resectable Cancer | NCT05747482 | Cancer of Stoma... | Surgery procedu... | 18 Years - | Corporacion Parc Tauli | |
| A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors | NCT03129139 | Advanced Cancer Gastric Cancer Breast Cancer Pancreatic Canc... Prostate Cancer... Colo-rectal Can... Solid Tumor Solid Carcinoma Solid Carcinoma... Cancer of Stoma... | Minnelide™Capsu... | 18 Years - | Minneamrita Therapeutics LLC | |
| Maintenance Treatment With S-1 in Gastric Cancer Patients | NCT03701373 | Gastric Cancer ... Cancer of Stoma... | S-1 maintenance Observation | 18 Years - 80 Years | Sun Yat-sen University | |
| Selective COX-II Inhibitor as a Palliative Therapy in Patients With R1 or R2 Resection for Disseminated Stomach Cancer - A Multi-Centre Prospective Randomized Controlled Trial | NCT00165048 | Cancer of Stoma... | Vioxx (Rofecoxi... | 18 Years - 80 Years | Chinese University of Hong Kong | |
| GLIM-defined Malnutrition Criteria for Postoperative Outcomes in Patients With Esophagogastric Cancer | NCT05088304 | Cancer of Stoma... Cancer of Esoph... Malnutrition Muscle Loss | no intervention | 18 Years - | Jinling Hospital, China | |
| Wet Heparinized Suction for Abdominal Cancer | NCT05041335 | Cancer of Pancr... Cancer of Stoma... Cancer of Esoph... Cancer of Liver Cancer | wet heparinzed ... Microsieve No heparin flus... No microsieve | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Improving Goals of Care Discussion in Advanced Cancer Patients | NCT02374255 | Primary Stage I... Esophageal Colorectal Canc... Glioblastoma Cancer of Stoma... Cancer of Pancr... Melanoma Head or Neck Ca... Stage III Stage IV Lung Cancers Pancreatic Canc... | GoC interventio... | 21 Years - | Icahn School of Medicine at Mount Sinai | |
| Early Support in Primary Care for People Starting Treatment for Cancer | NCT03719716 | Cancer of Pancr... Cancer of Stoma... Cancer of Esoph... | Anticipatory ca... | 18 Years - | NHS Lothian | |
| Nordic Gastric and Esophageal Tumor Study | NCT05688761 | Cancer of Stoma... Cancer of the E... Drug Use | Proton pump inh... | 18 Years - | Karolinska Institutet | |
| Medical Consortium for Screening Upper Gastrointestinal Cancers With Magnetically Controlled Capsule Gastroscopy | NCT04032353 | Capsule Endosco... Cancer of Stoma... Cancer of Esoph... Health Policy | Medical Consort... | 18 Years - 80 Years | Shandong University | |
| Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer | NCT02942329 | Gastric Cancer Hepatocellular ... | apatinib SHR-1210 | 18 Years - 70 Years | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | |
| Audit of the Spanish EURECCA Esophagogastric Cancer Registry | NCT03541629 | Cancer of Stoma... Cancer of Esoph... | - | Parc de Salut Mar | ||
| GLIM-defined Malnutrition Criteria for Postoperative Outcomes in Patients With Esophagogastric Cancer | NCT05088304 | Cancer of Stoma... Cancer of Esoph... Malnutrition Muscle Loss | no intervention | 18 Years - | Jinling Hospital, China | |
| Selective COX-II Inhibitor as an Adjuvant Therapy in Patients With Resectable Advanced Stomach Cancer ( Histological Staging ≥ T2N1) - A Multi-Centre Prospective Randomised Controlled Trial | NCT00164892 | Cancer of Stoma... | Oral Vioxx (Rof... | 18 Years - 80 Years | Chinese University of Hong Kong | |
| Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer | NCT03347162 | Cancer Cancer of Pancr... Cancer of Liver Cancer of Esoph... Cancer of Stoma... Cancer, Metasta... | 18 Years - | Rigshospitalet, Denmark | ||
| A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors | NCT03129139 | Advanced Cancer Gastric Cancer Breast Cancer Pancreatic Canc... Prostate Cancer... Colo-rectal Can... Solid Tumor Solid Carcinoma Solid Carcinoma... Cancer of Stoma... | Minnelide™Capsu... | 18 Years - | Minneamrita Therapeutics LLC | |
| Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer | NCT02942329 | Gastric Cancer Hepatocellular ... | apatinib SHR-1210 | 18 Years - 70 Years | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | |
| Audit of the Spanish EURECCA Esophagogastric Cancer Registry | NCT03541629 | Cancer of Stoma... Cancer of Esoph... | - | Parc de Salut Mar | ||
| Investigation of an Abdominal Compression Device | NCT04270890 | Cancer, Lung Cancer of Stoma... | Abdominal compr... | 18 Years - | The Clatterbridge Cancer Centre NHS Foundation Trust | |
| The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) | NCT03896958 | Cancer, All Typ... Cancer of Liver Cancer of Stoma... Cancer of Head ... Cancer of Rectu... Cancer of Kidne... Cancer of Esoph... Cancer of Colon Cancer Skin Cancer of Cervi... Cancer, Metasta... Cancer of Laryn... Cancer of Neck Cancer of Lung Cancer of Brain... Cancer of Vulva... Cancer of Pancr... Sarcoma GIST Small-cell Lung... Adenocarcinoma ... Cancer of Prost... Cancer, Advance... Adrenal Cancer Testicular Canc... Uterine Cancer Bronchoalveolar... Cancer Unknown ... Glioblastoma Mu... Oligodendroglio... Breast Cancer Renal Cell Carc... Hepatocellular ... Cholangiocarcin... Squamous Cell C... Transitional Ce... Cancer, Other Cancer, Anal Melanoma Cancer, Bile Du... Cancer, Bladder Cancer Cords Vo... Cancers Cell Ne... Cancer Differen... Cancer, Anaplas... | 1 Month - 99 Years | SpeciCare | ||
| NAB-PACLITAXEL Plus FOLFOX as Perioperative Chemotherapy in Patients With Operable Oesogastric Adenocarcinoma | NCT02486601 | Cancer of Stoma... | nab-paclitaxel FOLFOX | 18 Years - | GERCOR - Multidisciplinary Oncology Cooperative Group | |
| A Phase 3 Study to Compare Efficacy and Safety of DHP107 Versus Taxol® in Patients With Metastatic or Recurrent Gastric Cancer After Failure of First-line Chemotherapy | NCT01839773 | Stage IV Gastri... | Paclitaxel Paclitaxel | 20 Years - | Daehwa Pharmaceutical Co., Ltd. | |
| Maintenance Treatment With S-1 in Gastric Cancer Patients | NCT03701373 | Gastric Cancer ... Cancer of Stoma... | S-1 maintenance Observation | 18 Years - 80 Years | Sun Yat-sen University | |
| Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal Junction | NCT00080002 | Cancer of Stoma... Gastroesophagea... | Pegamotecan | 18 Years - | Enzon Pharmaceuticals, Inc. | |
| The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) | NCT03896958 | Cancer, All Typ... Cancer of Liver Cancer of Stoma... Cancer of Head ... Cancer of Rectu... Cancer of Kidne... Cancer of Esoph... Cancer of Colon Cancer Skin Cancer of Cervi... Cancer, Metasta... Cancer of Laryn... Cancer of Neck Cancer of Lung Cancer of Brain... Cancer of Vulva... Cancer of Pancr... Sarcoma GIST Small-cell Lung... Adenocarcinoma ... Cancer of Prost... Cancer, Advance... Adrenal Cancer Testicular Canc... Uterine Cancer Bronchoalveolar... Cancer Unknown ... Glioblastoma Mu... Oligodendroglio... Breast Cancer Renal Cell Carc... Hepatocellular ... Cholangiocarcin... Squamous Cell C... Transitional Ce... Cancer, Other Cancer, Anal Melanoma Cancer, Bile Du... Cancer, Bladder Cancer Cords Vo... Cancers Cell Ne... Cancer Differen... Cancer, Anaplas... | 1 Month - 99 Years | SpeciCare | ||
| Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer | NCT00201747 | Esophageal Canc... Esophagus Cance... Cancer of Stoma... Stomach Cancer | CPT-11 Mitomycin C | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors | NCT03129139 | Advanced Cancer Gastric Cancer Breast Cancer Pancreatic Canc... Prostate Cancer... Colo-rectal Can... Solid Tumor Solid Carcinoma Solid Carcinoma... Cancer of Stoma... | Minnelide™Capsu... | 18 Years - | Minneamrita Therapeutics LLC | |
| A Clinical Trial Evaluating the Effect of ASLAN001 in Patients With Recurrent/Metastatic Gastric Cancer Whose Tumors Are Either HER-2 Amplified or Co-expressing HER-1 and HER-2 | NCT01614522 | Stomach Neoplas... Cancer of Stoma... Cancer of the S... Gastric Cancer Gastric Neoplas... | ASLAN001 | 21 Years - | ASLAN Pharmaceuticals | |
| Selective COX-II Inhibitor as an Adjuvant Therapy in Patients With Resectable Advanced Stomach Cancer ( Histological Staging ≥ T2N1) - A Multi-Centre Prospective Randomised Controlled Trial | NCT00164892 | Cancer of Stoma... | Oral Vioxx (Rof... | 18 Years - 80 Years | Chinese University of Hong Kong | |
| Early Support in Primary Care for People Starting Treatment for Cancer | NCT03719716 | Cancer of Pancr... Cancer of Stoma... Cancer of Esoph... | Anticipatory ca... | 18 Years - | NHS Lothian | |
| Nordic Gastric and Esophageal Tumor Study | NCT05688761 | Cancer of Stoma... Cancer of the E... Drug Use | Proton pump inh... | 18 Years - | Karolinska Institutet | |
| A Clinical Trial Evaluating the Effect of ASLAN001 in Patients With Recurrent/Metastatic Gastric Cancer Whose Tumors Are Either HER-2 Amplified or Co-expressing HER-1 and HER-2 | NCT01614522 | Stomach Neoplas... Cancer of Stoma... Cancer of the S... Gastric Cancer Gastric Neoplas... | ASLAN001 | 21 Years - | ASLAN Pharmaceuticals | |
| Real-time Activity Monitoring to Prevent Admissions During RadioTherapy | NCT03102229 | Cancer of the H... Cancer of Lung Cancer of Esoph... Cancer of Stoma... | Enhanced Suppor... Enhanced Suppor... | 18 Years - | Albert Einstein College of Medicine | |
| Improving Goals of Care Discussion in Advanced Cancer Patients | NCT02374255 | Primary Stage I... Esophageal Colorectal Canc... Glioblastoma Cancer of Stoma... Cancer of Pancr... Melanoma Head or Neck Ca... Stage III Stage IV Lung Cancers Pancreatic Canc... | GoC interventio... | 21 Years - | Icahn School of Medicine at Mount Sinai | |
| GLIM-defined Malnutrition Criteria for Postoperative Outcomes in Patients With Esophagogastric Cancer | NCT05088304 | Cancer of Stoma... Cancer of Esoph... Malnutrition Muscle Loss | no intervention | 18 Years - | Jinling Hospital, China | |
| Real-time Activity Monitoring to Prevent Admissions During RadioTherapy | NCT03102229 | Cancer of the H... Cancer of Lung Cancer of Esoph... Cancer of Stoma... | Enhanced Suppor... Enhanced Suppor... | 18 Years - | Albert Einstein College of Medicine | |
| Laparoscopic D2 Distal Gastrectomy Following Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancers | NCT03468712 | Complications, ... Surgery--Compli... Cancer of Stoma... Chemotherapy Ef... | Laparoscopic D2... | 18 Years - 75 Years | West China Hospital | |
| Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer | NCT00201747 | Esophageal Canc... Esophagus Cance... Cancer of Stoma... Stomach Cancer | CPT-11 Mitomycin C | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study | NCT05804331 | Cancer of Stoma... Oesophageal Can... Gastric Cancer Gastric Adenoca... GI Cancer GIST Neuroendocrine ... Gastric Neoplas... Esophageal Neop... | 18 Years - | Western Sydney Local Health District | ||
| Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer | NCT03775525 | Advanced Cancer Gastric Cancer Breast Cancer Pancreatic Canc... Prostate Cancer... Colo-rectal Can... Solid Tumor Solid Carcinoma Solid Carcinoma... Cancer of Stoma... Lymphoma Sarcoma Cutaneous T Cel... Head and Neck S... Basal Cell Carc... Cutaneous T-cel... Cutaneous Squam... | GZ17-6.02 Capecitabine | 18 Years - | Genzada Pharmaceuticals USA, Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
